Fortress Biotech (FBIO) Non Operating Income (2011 - 2026)

Fortress Biotech's Non Operating Income history runs 14 years deep, the most recent figure standing at -$1.4 million for Q4 2025.

• In Q4 2025, Non Operating Income rose 33.58% year-over-year to -$1.4 million; the TTM figure through Dec 2025 stood at $36.7 million (up 460.82% YoY), while the FY2025 annual figure was $36.7 million, up 460.94% from the prior year.
• Non Operating Income for Q4 2025 stood at -$1.4 million, down from $15.7 million in the prior quarter.
• The five-year high for Non Operating Income was $24.8 million in Q2 2025, with the low at -$9.2 million in Q2 2023.
• The 5-year median for Non Operating Income is -$2.2 million (2022), against an average of $1.3 million.
• The sharpest annual moves came in 2023 and 2025: Non Operating Income slumped 280.65% in 2023, then surged 2495.66% in 2025.
• Fortress Biotech's Non Operating Income stood at -$6.0 million in 2021, then surged by 60.86% to -$2.4 million in 2022, then plunged by 280.65% to -$9.0 million in 2023, then surged by 76.15% to -$2.1 million in 2024, then soared by 33.58% to -$1.4 million in 2025.
• Business Quant data shows FBIO's Non Operating Income at -$1.4 million in Q4 2025, $15.7 million in Q3 2025, and $24.8 million in Q2 2025.